POSITION SUMMARY
The Associate Director, Clinical Science is responsible for the planning, execution and operational oversight of clinical development programs supporting the advancement of eGenesis’ pipeline. Working with cross-functional teams, this role will ensure the scientific integrity, operational excellence and timely execution of clinical studies. The successful candidate will contribute to the design and execution of clinical development strategies, support regulatory submissions, and drive continuous improvement across clinical development processes and initiatives in a collaborative, science-driven biotech environment.
PRIMARY RESPONSIBILITIES
- Support the design and implementation of early and late-stage clinical projects and ensure that the overall scientific and medical content of all clinical programs is scientifically and clinically rigorous
- Develop and maintain clinical development plans that integrate preclinical, translational, and clinical data while ensuring alignment across cross-functional teams
- Design scientifically rigorous, operationally feasible, and cost-effective clinical protocols aligned with the overall clinical development plan
- Present clinical protocols, development plans, and study updates to internal governance committees and senior leadership
- Serve as the Clinical Science representative on cross-functional project teams
- Partner closely with the Medical Monitor to oversee study conduct, monitor study progress, and ensure protocol compliance
- Lead data review, evaluation, and analyses in collaboration with Data Management and Biostatistics and Statistical Programming teams
- Contribute to the preparation of clinical sections of regulatory submissions and supporting documents, including INDs, briefing documents, BLAs, Safety and Annual reports, and responses to regulatory agencies regarding questions about clinical development issues (e.g., safety or efficacy)
- Ensure compliance with applicable regulations, clinical R&D policies, SOPs and quality standards
- Support scientific due diligence activities, including preparing and presenting medically-sound strategies and plans associated with advanced opportunities
- Drive continuous improvement to enhance Clinical Development processes, study execution and cross-functional collaboration
QUALIFICATIONS
- PharmD or PhD with 7+ years of clinical science experience in a biotech or pharmaceutical company, or CRO environment
- Experience in clinical development and/or translational science required
- Strong understanding of clinical trial design, data collection standards, and GCP guidelines
- Strong analytical skills with the ability to analyze and compile complex clinical data
- Strong experience working with vendors and clinical sites
- Excellent communication and collaboration skills with both internal teams and external partners
- Proven leadership skills and demonstrated ability to interact collaboratively in a cross-functional environment.
- Excellent oral and written communication skills, including proficiency with Excel and PowerPoint
Skills Required
- PharmD or PhD with 7+ years of clinical science experience in a biotech, pharmaceutical company, or CRO
- Experience in clinical development and/or translational science
- Strong understanding of clinical trial design, data collection standards, and GCP guidelines
- Strong analytical skills with the ability to analyze and compile complex clinical data
- Strong experience working with vendors and clinical sites
- Proven leadership skills and ability to collaborate in cross-functional teams
- Excellent oral and written communication skills
- Proficiency with Excel and PowerPoint
What We Do
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis has the capability to solve the global organ crisis by providing an alternative to allotransplantation. eGenesis is uniquely positioned to reinvigorate the field of xenotransplantation by addressing both the key virology and immunology hurdles that have impeded its advancement to date and provide commercially-viable products to save and enhance the lives of patients in need.
